EGFRvIII is specifically expressed in 31% of primary GBM patients, and compared to patients with wild-type EGFR GBM, those with EGFR-mutant GBM tend to have an older age at diagnosis, worse prognosis, and resistance to chemoradiotherapy (119, 120). Here, EGFR is linked to glioblastoma.